Latest filing published 10 Aug 2026 for BlossomHill Therapeutics, Inc..
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Yishan Li: trading record in brief
Yishan Li appears in our data through filings on BlossomHill Therapeutics, Inc. shares, published by SEC (Form 4). Altogether 3 filings, all relating to 10 August 2026.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The latest filing, published on 10 August 2026, reports a transaction in BlossomHill Therapeutics, Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Yishan Li
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,600,682 sharesCommon StockSEC:0001772233-26-000005:0
- 113,435 sharesCommon StockSEC:0001772233-26-000005:1
- 124,779 sharesCommon StockSEC:0001772233-26-000005:2
3 of 3 declarations
